Nobivac Solvent

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

See SPC

متاح من:

MSD Animal Health UK Limited

INN (الاسم الدولي):

See SPC

الشكل الصيدلاني:

Solution for injection

نوع الوصفة الطبية :

POM-V - Prescription Only Medicine – Veterinarian

المجموعة العلاجية:

Cats, Dogs

المجال العلاجي:

Diluent

الوضع إذن:

Authorized

تاريخ الترخيص:

2005-10-28

خصائص المنتج

Revised: November 2020
AN: 01069/2020
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE PRODUCT
Nobivac Solvent
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION OF PRODUCT
ACTIVE INGREDIENT
PER 1 ML
Not applicable.
For full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
A clear colourless liquid solvent for parenteral use, consisting of
sterile phosphate-
buffered water presented in single 1 ml vials.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE SPECIFYING THE TARGET SPECIES
To reconstitute freeze dried small animal Nobivac vaccines which
include instructions
to be reconstituted with Nobivac Solvent.
4.3
CONTRAINDICATIONS
Any contra-indications specified for the vaccine for which the Nobivac
Solvent is used
for reconstitution will apply.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN
BY
THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
No special precautions are required for handling the solvent however
any
recommendations specified for the vaccine for which Nobivac Solvent is
used for
reconstitution will apply.
Sterile equipment should be used for administration. Avoid
contamination of vaccine
Revised: November 2020
AN: 01069/2020
Page 2 of 4
with traces of chemical sterilising agents. Do not use chemicals such
as disinfectant
or spirit to disinfect the skin prior to inoculation.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
In case of accidental self-injection, seek medical advice immediately
and show the
package leaflet or the label to the physician.
After reconstitution: Any recommendations specified for the vaccine
for which
Nobivac Solvent is used for reconstitution will apply.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Any adverse reaction specified for the vaccine for which Nobivac
Solvent is used for
reconstitution will apply.
4.7
USE DURING PREGNANCY, LACTATION